Comments
Dr Reddy’s Laboratories has received an establishment inspection report (EIR) from the US health regulator following audit of its UK facility. The USFDA issues an EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection. In September last year, the US Food and Drug Administration had made three observations after inspecting Dr Reddy’s Laboratories’ API Mirfield (United Kingdom) plant. Shares of Dr Reddy’s Laboratories gained 1 per cent at ₹2,156.25 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.